Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A0YC5W / Name: Arcus / Stock / Metals & Mining / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Arcus Development Group Stock

Pros and Cons of Arcus Development Group in the next few years

Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Arcus Development Group vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Arcus Development Group - - - - - - -
Chatham Rock Phosphate Ltd -25.000% -41.176% -9.091% -81.481% -78.261% -93.506% -
Cannabix Techs Inc. -0.530% -2.020% -13.393% 6.593% 8.380% 101.036% -47.211%
Mundoro Capital Inc. 1.770% -14.063% -27.632% 100.000% 65.414% 91.304% 67.939%

News

Arcus Capital Scales Back Dream Finders Homes Stake, According to Recent SEC Filing: https://cdn.content.foolcdn.com/images/1umn9qeh/production/5a835a403d8e07011d119675ff444b39fb510d2f-1401x1251.png?w=800&q=75&fit=max&auto=format
Arcus Capital Scales Back Dream Finders Homes Stake, According to Recent SEC Filing

According to a Securities and Exchange Commission (SEC) filing dated May 6, 2026, Arcus Capital Partners, LLC reduced its stake in Dream Finders Homes (NYSE:DFH) by 398,536 shares during the first

Arcus Biosciences President Sells $2 Million as Stock Delivers 48% Annual Return
Arcus Biosciences President Sells $2 Million as Stock Delivers 48% Annual Return

On Dec. 4, 2025, Juan C. Jaen, President of Arcus Biosciences (NYSE:RCUS), disposed of 82,997 shares in an open-market transaction via an indirect holding, generating a transaction value of